Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)
Clinical trial NCT01945814 · COMPLETED
Trial details
- NCT number
- NCT01945814
- Sponsor
- Catherine Bollard
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2017-10-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.